These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 31389621)

  • 1. Feasibility of an intervention for men on androgen deprivation therapy: A research protocol.
    Manson A; Myers J; Billinger S; Ward J; Parker W; Hamilton-Reeves J; Michel C; Maliski SL
    Res Nurs Health; 2019 Oct; 42(5):324-333. PubMed ID: 31389621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective, randomized pilot study evaluating the effects of metformin and lifestyle intervention on patients with prostate cancer receiving androgen deprivation therapy.
    Nobes JP; Langley SE; Klopper T; Russell-Jones D; Laing RW
    BJU Int; 2012 May; 109(10):1495-502. PubMed ID: 21933330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Individualized Diet and Exercise Adherence Pilot Trial (IDEA-P) in prostate cancer patients undergoing androgen deprivation therapy: study protocol for a randomized controlled trial.
    Focht BC; Lucas AR; Grainger E; Simpson C; Thomas-Ahner JM; Clinton SK
    Trials; 2014 Sep; 15():354. PubMed ID: 25199619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of a lifestyle intervention on endothelial function in men on long-term androgen deprivation therapy for prostate cancer.
    Gilbert SE; Tew GA; Fairhurst C; Bourke L; Saxton JM; Winter EM; Rosario DJ
    Br J Cancer; 2016 Feb; 114(4):401-8. PubMed ID: 26766737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of a Group-Mediated Exercise and Dietary Intervention in the Treatment of Prostate Cancer Patients Undergoing Androgen Deprivation Therapy: Results From the IDEA-P Trial.
    Focht BC; Lucas AR; Grainger E; Simpson C; Fairman CM; Thomas-Ahner JM; Buell J; Monk JP; Mortazavi A; Clinton SK
    Ann Behav Med; 2018 Apr; 52(5):412-428. PubMed ID: 29684136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of exercise in the management of adverse effects of androgen deprivation therapy for prostate cancer: a rapid review.
    Edmunds K; Tuffaha H; Scuffham P; Galvão DA; Newton RU
    Support Care Cancer; 2020 Dec; 28(12):5661-5671. PubMed ID: 32699997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgen deprivation therapy: evidence-based management of side effects.
    Ahmadi H; Daneshmand S
    BJU Int; 2013 Apr; 111(4):543-8. PubMed ID: 23351025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pilot study of exercise in men with prostate cancer receiving androgen deprivation therapy.
    Lee CE; Leslie WD; Lau YK
    BMC Cancer; 2012 Mar; 12():103. PubMed ID: 22436542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse effects of androgen deprivation therapy and strategies to mitigate them.
    Nguyen PL; Alibhai SM; Basaria S; D'Amico AV; Kantoff PW; Keating NL; Penson DF; Rosario DJ; Tombal B; Smith MR
    Eur Urol; 2015 May; 67(5):825-36. PubMed ID: 25097095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of exercise interventions to overcome adverse effects of androgen deprivation therapy.
    Østergren PB; Kistorp C; Bennedbæk FN; Faber J; Sønksen J; Fode M
    Nat Rev Urol; 2016 Jun; 13(6):353-64. PubMed ID: 27112391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lifestyle changes for improving disease-specific quality of life in sedentary men on long-term androgen-deprivation therapy for advanced prostate cancer: a randomised controlled trial.
    Bourke L; Gilbert S; Hooper R; Steed LA; Joshi M; Catto JW; Saxton JM; Rosario DJ
    Eur Urol; 2014 May; 65(5):865-72. PubMed ID: 24119318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate cancer survivorship: prevention and treatment of the adverse effects of androgen deprivation therapy.
    Saylor PJ; Keating NL; Smith MR
    J Gen Intern Med; 2009 Nov; 24 Suppl 2(Suppl 2):S389-94. PubMed ID: 19838837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgen deprivation therapy increases cardiovascular morbidity in men with prostate cancer.
    Saigal CS; Gore JL; Krupski TL; Hanley J; Schonlau M; Litwin MS;
    Cancer; 2007 Oct; 110(7):1493-500. PubMed ID: 17657815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen deprivation therapy in men with prostate cancer: how should the side effects be monitored and treated?
    Grossmann M; Zajac JD
    Clin Endocrinol (Oxf); 2011 Mar; 74(3):289-93. PubMed ID: 21092052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility and safety of physical exercise in men with prostate cancer receiving androgen deprivation therapy and radiotherapy: a study protocol.
    Bressi B; Iotti C; Cagliari M; Cavuto S; Fugazzaro S; Costi S
    BMJ Open; 2022 Mar; 12(3):e048854. PubMed ID: 35292485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can exercise ameliorate the increased risk of cardiovascular disease and diabetes associated with ADT?
    Galvão DA; Newton RU; Taaffe DR; Spry N
    Nat Clin Pract Urol; 2008 Jun; 5(6):306-7. PubMed ID: 18431358
    [No Abstract]   [Full Text] [Related]  

  • 17. Cardiovascular risk with androgen deprivation therapy for prostate cancer: potential mechanisms.
    Tivesten Å; Pinthus JH; Clarke N; Duivenvoorden W; Nilsson J
    Urol Oncol; 2015 Nov; 33(11):464-75. PubMed ID: 26141678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mediterranean-style dietary pattern improves cancer-related fatigue and quality of life in men with prostate cancer treated with androgen deprivation therapy: A pilot randomised control trial.
    Baguley BJ; Skinner TL; Jenkins DG; Wright ORL
    Clin Nutr; 2021 Jan; 40(1):245-254. PubMed ID: 32534948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effectiveness of lifestyle interventions to reduce side effects of androgen deprivation therapy for men with prostate cancer: a systematic review.
    Geerkens MJM; Pouwels NSA; Beerlage HP
    Qual Life Res; 2020 Apr; 29(4):843-865. PubMed ID: 31832978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical importance of quantifying body fat distribution during androgen deprivation therapy for prostate cancer.
    Foulkes SJ; Daly RM; Fraser SF
    Endocr Relat Cancer; 2017 Mar; 24(3):R35-R48. PubMed ID: 28062546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.